Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaElena J. Orlando, Wendy Winckler, Rebecca Leary et al.|Nature Medicine|2018Cited by 577
Identification and Characterization of 4-Methylbenzyl 4-[(Pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an Orally Bioavailable, Brain Penetrant NR2B Selective<i>N</i>-Methyl-<scp>d</scp>-Aspartate Receptor AntagonistNigel J. Liverton, Kenneth S. Koblan, Rodney A. Bednar et al.|Journal of Medicinal Chemistry|2007Cited by 45